Log in or Sign up for Free to view tailored content for your specialty!
Vasculitis and Giant Cell Arteritis News
ACR, Vasculitis Foundation guideline emphasizes prompt IVIG for Kawasaki disease
The American College of Rheumatology and the Vasculitis Foundation have released new guidelines for Kawasaki disease, focusing on diagnostic issues, high-risk patients and convalescent patient management.
Nintedanib slows FVC decline in autoimmune-related interstitial lung disease
Nintedanib slows the rate of forced vital capacity decline in patients with fibrosing autoimmune disease-related interstitial lung disease, with adverse events manageable for most, according to data published in Arthritis & Rheumatology.
Log in or Sign up for Free to view tailored content for your specialty!
Post-vaccine seronegativity predicts breakthrough COVID-19 in patients with AIRD
Lack of antibody response following COVID-19 vaccination is the strongest predictor of breakthrough infection in patients with autoimmune rheumatic disease, according to data published in Annals of the Rheumatic Diseases.
Rhinovirus, RSV, varicella infections precede Kawasaki disease outbreaks by 1 to 3 months
Infections caused by rhinovirus, respiratory syncytial virus and varicella, precede Kawasaki disease outbreaks by 1 to 3 months in children and young adults in South Korea, according to data published in JAMA Network Open.
Leadership, Research and Patient Care with Kristin Highland, MS, MD
Kristin B. Highland, MD, does it all and makes it look easy. In this episode, we discuss how to follow your dreams, balance your life and define success on your own terms.
Older woman develops acute, painless, monocular vision loss
An 88-year-old woman developed an acute onset of painless, monocular vision loss in the right eye.
Flares, breakthroughs rare after COVID-19 vaccination in inflammatory rheumatic disease
Just 0.7% of fully vaccinated patients with inflammatory rheumatic and musculoskeletal disease experience a breakthrough COVID-19 infection, while only 4.4% demonstrate disease flare reactions, according to data.
DMARD interruptions rose 80% in early 2021 among autoimmune rheumatic patients
DMARD interruptions in patients with autoimmune rheumatic diseases increased more than 80% between December 2020 and May 2021, leading to higher rates of self-reported flares, according to data published in Arthritis Care & Research.
Tocilizumab delays flare, reduces glucocorticoid dose in new-onset giant cell arteritis
Weekly tocilizumab delays initial flare and reduces glucocorticoid exposure in patients with relapsing and new-onset giant cell arteritis, according to data published in Rheumatology.
Rare autoimmune rheumatic diseases more than double risk for COVID-19 death
Patients with rare autoimmune rheumatic diseases have a 54% increased risk for COVID-19 infection, and more than twice the risk for COVID-19 death, versus the general population, according to data published in Rheumatology.
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read